Nine Chapters Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Nine Chapters Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-22,500	Closed	-$513K	–	1258
2015 Q2	$513K	Buy	+22,500	New	+$448K	0.04%	567
2014 Q2	–	Sell	-43,900	Closed	-$511K	–	1188
2014 Q1	$511K	Sell	43,900 -19,400	-31%	-$329K	0.06%	444
2013 Q4	$1.12M	Buy	63,300 +14,900	+31%	+$250K	0.11%	264
2013 Q3	$696K	Buy	+48,400	New	+$741K	0.08%	336

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

Nine Chapters Capital Management's MNTA Position: Q3 2015 in Review

Nine Chapters Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2015, closing a stake of 22,500 shares — an estimated $513K sold.

Nine Chapters Capital Management first reported a position in MNTA in Q3 2013 and held it in 4 quarters. The position peaked at $1.12M in Q4 2013. 156 funds tracked by Wall St. Rank hold MNTA as of Q3 2015.

Nine Chapters Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
Nine Chapters Capital Management sold 22,500 Momenta Pharmaceuticals, Inc. shares in Q3 2015, an estimated $513K.
Nine Chapters Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2013 and held it in 4 quarters.
Nine Chapters Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $1.12M in Q4 2013.
156 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2015.

Based on Nine Chapters Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.